Cell Surface Engineering of Glycosaminoglycan Mimetics for Targeting Parkinson’s Disease
ISEF · 2018 Biochemistry Fourth Award
Overview
The reduction of dopamine levels due to the malfunction of dopaminergic neurons results in Parkinson’s Disease (PD). Current treatments, lacking neuroprotective functions, face challenges in endogenous dopamine production. Thus, enhancing neuroprotective pathways for survival of dopaminergic neurons is key in advancing treatments for PD. Glial cell line-derived neurotrophic factor (GDNF) is a growth factor shown to enable neurite outgrowth and is thus vital to development of dopaminergic neurons. GDNF requires Heparan Sulfate (HS), a class of glycosaminoglycans (GAGs) to activate its c-Ret receptor, making HS a potential therapeutic. However, homogenous HS is difficult to access from natural sources, limiting applications. Since sulfation patterns of HS give rise to protein specific HS-GDNF interactions, current GAG mimetics, lacking precise control of sulfate presentation, limit tailored GAG-mediated signaling. To overcome such challenges, a novel GAG mimetic was synthesized, achieving optimal GDNF recognition by precisely controlling spatial arrangements of sulfated motifs via a structurally well-defined polyproline scaffold, characterized by Circular Dichroism Spectroscopy. Surface Plasmon Resonance study has shown that the mimetic binds to GDNF with high affinity due to good geometrical fit of sulfate groups to postulated HS-GDNF binding sites identified through computational studies. The mimetic’s ability to increase GDNF-mediated neuronal signaling was further proven by successfully introducing mimetic onto PC12 cell surface and enhancing neurite outgrowth on PC12 cells through GDNF-GFRa1 mediated pathway. The findings of this study reflect a promising strategy for engineering GAG mediated neural processes and a novel therapeutic agent for Parkinson’s disease.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2018
Resources
Related projects
ISEF · 2024
Biomedically Functional Sugars: Transforming Glycan-Based Drug Design Through Streamlined Methods and Novel Metabolic Glycan Tracking
ISEF · 2016
A Novel Approach to Guiding Neurogenesis: Manipulation of Neural Stem Cell Differentiation and Growth Using Glycan-Based Small Molecules
ISEF · 2026
Inducible TLR4 Decoy for Targeting Microglial Activation to Reduce Neuronal Degeneration in Parkinson's Disease
ISEF · 2017
Ameliorating Alpha-Synuclein Aggregation in Parkinson's Using Optimized Chaperones: An in silico Approach
ISEF · 2025
Paving the Path to the Impossible: Regenerating Neurons Using Prostaglandin E2 Regulation as a Therapeutic Strategy
ISEF · 2026
Frankenstein-Synuclein: Rapid, Structure-Informed in silico Generation of de novo Replacement Protein Variants Using Benign Homologs for Parkinson's Disease Prevention
ISEF · 2014
Biochemical Analysis of Post Translation Modification to the Parkinson's Disease Protein Alpha-Synuclein
ISEF · 2017
Engineering Surface Chemistries to Improve Tissue-Material Integration in Medical Implants
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair